ConductScience.org, home

Paper · 58934

Induction of specific suppressor T cells in vitro.

Eardley DD and 1 other. J Immunol, 1976. Cited by 130 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Induction of specific suppressor T cells in vitro. Papers, record 58934. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/58934

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of specific suppressor T cells in vitro.
PubMed
Journal
J Immunol
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
130
iCite
Relative citation ratio, by iCite
3.28
iCite
Revised in PubMed
2021-12-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eardley DDD D
2Gershon RKR K

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunosuppression TherapyMajor topic
T-LymphocytesMajor topic
Animals
Carrier Proteins
Epitopes
Immunologic Memory
Male
Mercaptoethanol
Mice
Mice, Inbred C57BL
Mice, Inbred DBA
Pactamycin
Radiation Effects
Time Factors
X-Rays

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.

PMIDTitleJournalYearIn PapersSource
32,421,955Advances in the Study of CD8+ Regulatory T Cells.Crit Rev Immunol2019https://conductscience.org/library/papers/32421955PubMed
23,017,141Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.Immunol Invest2012https://conductscience.org/library/papers/23017141PubMed
7,019,050Enhancement of the in vitro antibody response in dietary protein restriction. Failure in the regulation of antibody synthesis.Immunology1981https://conductscience.org/library/papers/7019050PubMed
6,811,173The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines.Clin Exp Immunol1982https://conductscience.org/library/papers/6811173PubMed
6,456,322Mechanisms of idiotype suppression. IV. Functional neutralization in mixtures of idiotype-specific suppressor and hapten-specific suppressor T cells.J Exp Med1981https://conductscience.org/library/papers/6456322PubMed
6,455,665Functional deletion of different Ly-1 T-cell-inducer subset activities by Ly-2 suppressor T lymphocytes.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6455665PubMed
6,450,652Thymic function in NZB mice. III. Impairment of the activity of specific suppressor cells involved in the regulation of antibody production against sheep red blood cells.Clin Exp Immunol1980https://conductscience.org/library/papers/6450652PubMed
6,445,400Antigen-specific T cell-mediated suppression. V. H-2-linked genetic control of distinct antigen-specific defects in the production and activity of L-glutamic acid50-L-tyrosine50 suppressor factor.J Exp Med1980https://conductscience.org/library/papers/6445400PubMed
6,444,664Feedback suppression of the immune response in vitro. II. IgVH-restricted antibody-dependent suppression.J Exp Med1980https://conductscience.org/library/papers/6444664PubMed
6,444,663Feedback suppression of the immune response in vitro. I. Activity of antigen-stimulated B cells.J Exp Med1980https://conductscience.org/library/papers/6444663PubMed

1 to 10 of 33

See all 33 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/58934

GET https://conductscience.org/api/papers/v1/58934/cited_by?page=2